The purpose of this study is to review Candida isolation from urine of urinary tract infection (UTI) patients over the recent 3 years at the Kobe University Hospital. We recorded the type of strain, the department where the patient was treated such as the intensive care unit (ICU), and combined isolation of Candida with other microorganisms. We investigated Candida isolation and susceptibilities to antifungal agents and analyzed the risk factors for combined isolation with other microorganisms. The most frequently isolated Candida was Candida albicans, which showed good (100%) susceptibilities to 5-fluorocytosine (5-FC) and fluconazole (FLCZ) but not to voriconazole (VRCZ), followed by C. glabrata. ICU was the greatest source of Candida-positive samples, and the most relevant underlying diseases of ICU patients were pneumonia followed by renal failure and post liver transplantation status. Combined isolation with other bacteria was seen in 27 cases (42.9%) in 2009, 25 (33.3%) in 2010 and 31 (31.3%) in 2011 and comparatively often seen in non-ICU patients. Other candidas than C. albicans showed significantly decreased susceptibility to FLCZ over these 3 years (P ¼ 0.004). One hundred (97.1%) of 103 ICU cases were given antibiotics at the time of Candida isolation, and the most often used antibiotics were cefazolin or meropenem. In conclusion, C. albicans was representatively isolated in Candida UTI and showed good susceptibilities to 5-FC, FLCZ and VRCZ, but other candidas than C. albicans showed significantly decreased susceptibility to FLCZ in the change of these 3 years.
INTRODUCTION
The Infectious Diseases Society of America (IDSA) guideline was established in 2009 and it needs to evaluate the current trends of Candida urinary tract infection (UTI). [1] [2] [3] Several researchers have stated that Candida infections basically emerge only in immunecompromised hosts with dosing such as steroids, immune suppressants or chemotherapy. 2, 4, 5 However, other authors have found that while immune-compromised status is a risk factor for Candida infection, the patients with normal immune states may have a Candida infection, and culture tests should include those for fungus. [6] [7] [8] [9] In the absence of colonization, disseminated candidiasis is unlikely regardless of the presence of predisposing factors. 7 Urinary tract mycosis may often result from Candida UTI because of Candida's frequency of isolation in urine. 1, 10, 11 In general, Candida albicans is most often isolated in urine followed by C. glabrata or C. tropicallis. These strains show different trends in pathogenicity 10, 12, 13 and combined isolation with other microorganisms. 12 The detection of potential risk factors for Candida isolation are of clinical importance for understanding their extent of severities and for consideration of treatments, and Candida colonization may be considered as the factors for Candida infection. [14] [15] [16] Regarding treatments for Candida, several established antifungal agents are commercially available. 11, [17] [18] [19] These drugs are classified based on their targeting points. 20, 21 Candida susceptibilities to several antifungal agents may be decreasing according to recent trends. 22, 23 In this study, we reviewed the recent cases of Candida isolation from urine from UTI patients and Candida susceptibilities to antifungal agents over the last 3 years at the Kobe University Hospital, Kobe, Japan.
RESULTS

Candida isolation
Urinary tract Candida spp. was isolated over the last 3 years as shown in Table 1 . C. albicans was the most often isolated strain in all 3 years, followed by C. glabrata. Candida spp. was the most often isolated from intensive care unit (ICU) patients followed by the urological and general surgery departments (Table 1) . Details of patients' backgrounds of ICU cases and their antibiotic uses before Candida isolation were shown in Tables 2 and 3 . Shortly, the most relevant underlying diseases of ICU patients were pneumonia followed by renal failure or post-liver transplantation status. One hundred (97.1%) out of 103 ICU cases were given antibiotics at the time of Candida isolation, and the median duration of antibiotics usage was 10 days before Candida isolation. The median number of used antibiotics was two antibiotics and the most often used antibiotics were cefazolin and meropenem followed by vancomycin.
Our investigation of combined isolation with other microorganisms showed that 27 cases (42.9%) of isolated Candida in 2009, 25 (33.3%) in 2010 and 31 (31.3%) in 2011 had combined isolation with 
Susceptibilities to antifungal agents
We analyzed the data on Candida susceptibilities to representative antifungal agents. The data showed that over these 3 years C. albicans had good susceptibilities to 5-fluorocytosine (5-FC), fluconazole (FLCZ) and voriconazole (VRCZ); the susceptibility ratio was comparatively good (96.2 to 100%) ( Table 5 ). Other Candidas (C. glabrata, C. parapsilosis and C. tropicalis) had good susceptibilities to 5-FC and itraconazole (ITCZ) (100%), whereas susceptibility to FLCZ have become significantly lower (P ¼ 0.004) in the change of these 3 years investigated.
DISCUSSION
UTIs have been the focus of numerous studies, including optimal antibiotic treatments, the utility of urinary tract drainage, changes in causative microorganisms over time and in different regions and UTI categorization, such as complicated or uncomplicated UTI. 11, 24 This study focused on urinary tract mycosis, particularly Candida, which is comparatively often isolated from urine. 1, 11, 25 We found that C. albicans and C. glabrata dominated our isolation of Candida from urine, representing about 90% of all the Candida cultured from our urine samples, and this high prevalence ratio is similar to that in other studies. 10, 12, 13 Many cases involve multiple isolations with other microorganisms and Candida-related infections are also associated with immunecompromised patients. 1, 11 Immune-compromised patients easily become infected with mixed pathogenic microorganisms. 1 Fisher et al. 26 reported that C. albicans, compared with other Candida spp. such as C. glabrata, have the potential for strong adhesion, and this may be one reason for mixed infection or isolation with other microorganisms. The risks for these mixed isolations were reported by Sobel et al., 12 who found that more than one species of Candida were found simultaneously in over 10% of patients, and candiduria frequently coexists with or follows bacteriuria.
Our data showed that mixed isolation (two or more kinds of Candida isolated or combined isolation with other microorganisms) tended to be seen more often in non-ICU patients. In general in our medical system, ICU patients are in a hyper-acute phase or status, so the duration of hospitalization or medical interventions in most cases is shorter than for non-ICU patients, a category that includes the cases with long-hospital admission and associated hospital exposure. In addition, our data showed pneumonia, renal failure and post liver transplantation status were often seen in ICU cases and most of them (97.1%) were given antibiotics before Candida isolation. Fischer et al. 27 revealed that the important risk factors for severe fungal infection were frequent or long-term medical exposure or treatments such as antibiotic dosing. Lundstrom and Sobel 11 thought it is likely that antibiotics contribute to colonization by Candida spp. by suppressing endogenous bacterial flora. These works support our results and these kinds of studies need to be followed up in our medical system; debate persists on whether the Candida was isolated from UTI or colonization. Some authors have concluded that Candida isolation from urine is mostly due to medical devices such as urinary tract catheters and should be regarded as colonization in most cases, 25, 28, 29 requiring no treatments. Others conclude that Candida colonization is a definitive risk factor for Candida infections and these are often severe in immune-compromised hosts, including those undergoing chemotherapy or other immunesuppressant treatments, and in such cases Candida needs to be treated. 1, 2, 11 We suggest, considering our results of severity especially in ICU-patients shown in Table 2 , that the treatments in immunecompromised cases may be necessary like the latter opinions.
As to the susceptibilities to antifungal agents, our data showed that all our tested Candida spp. (C. albicans, C. glabrata, C. parapsilosis and C. tropicalis) had good susceptibilities to 5-FC, but other Candida than C. albicans showed decreased susceptibilities to FLCZ. These results were similar to those of Schmalreck et al. 23 who also reported decreased susceptibilities to FLCZ and VRCZ in C. glabrata and C. tropicalis, respectively. They also reported that a decreased susceptibility to 5-FC was found in C. tropicalis. Pemán et al. 30 showed that Candida spp. were all susceptible to 5-FC and VRCZ, but C. glabrata and C. krusei had decreased susceptibilities to these anti-fungal agents. Further, FLCZ failures of the treatment of C. glabrata causing renal infection have been reported with increasing frequency. 31 We would like to emphasize the limitations of this study. First, this study is retrospective and includes all the urine materials isolated regardless of infection or colonization. Next, the number of Candida cases may not be enough for definitive conclusions, however, these are the consecutive cases of our institution. Third, the patients' backgrounds were investigated only from ICU patients partly because those of non-ICU patients had wide range of variation and were considered difficult to be analyzed. These limitations should be resolved in our future investigation of urinary tract Candida.
In conclusion, we documented urinary tract Candida isolation and combined isolation with other microorganisms and found that the latter tended to be seen more commonly in non-ICU patients. Other Candidas than C. albicans showed decreasing susceptibility to FLCZ in the change of these 3 years (2009-2011). Further approaches to address Candida infection will be based on this baseline study evaluating urinary tract Candida institutionally.
METHODS Patients
Fungus was isolated from urine specimens from patients with UTI patients from January 2009 to December 2011 in Kobe University Hospital. We investigated the susceptibilities of isolated fungi to representative antifungal agents. UTI was defined as a symptomatic fungus isolation of 10 5 or more colony forming units per ml in urine. We recorded the patient's sex, type of strain, departments treating the patient, combined isolation with other microorganisms and analyzed the patients especially focusing on the categorization of ICU or non-ICU patients and antibiotics usage before Candida isolation in ICU patients.
Statistical analyses
Statistical analysis was conducted using linear regression analysis with PASW Statistics 17.0 software packages (for Windows; SPSS Inc., Chicago, IL, USA). The Candida susceptibilities of isolated strains to antifungal agents treatments were analyzed with linear regression analysis. Statistical significance was established at the 0.05 level.
